FDA Investigator Luella J Rossi

Luella J Rossi has inspections in 10 countries as of 06 Oct 2023. Luella J Rossi has collaborated with a combinined 4818 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
38
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100007172
Country:
Ireland, Czechia, Netherlands, Germany, France, United States of America, Italy, United Kingdom of Great Britain and Northern Ireland, Switzerland, Spain
Co-Investigator(s):
Alan P Kurtzberg, Alicia M Mozzachio, Allen Lou, Amir Alavi, Amy Chen, Amy N Chen, Andrace Lde Yampert, Andrea D Swingle, Anissa M Vargas, Anita R Michael, Anna Lazar, Arsen Karapetyan, Arthur T Ogdahl, Audrey Thereset Uy, Azza Talaat, Bei Y He, Benjamin J Smith, Bonita S Chester, Brooke K Higgins, Brooke K Seeman, Burnell M Henry, Byungja E Marciante, Candice C Mandera, Candice J Cortes, Carl A Huffman, III, Caroline Strasinger, Caryn M Mcnab, Charanjeet Jassal, Charles I Ann, Charles L Zhou, Charles M Edwards, Christina K Theodorou, Christopher S Keating, Christopher T Middendorf, Chryste D Best, Claire M Minden, Colleen M Damon, Constantin Y Philopoulos, Corrine M Carter, Craig D Zagata, Cynthia Jim, CSO, David A Paterson, David K Lau, Debara R Reese, Debara Reese, Deborah B Nixon, Debra I Love, Debra J Bennett, Dell S Moller, Denise L Burosh, Denise M Digiulio, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Dianne H Milazzo, Dina A Tallman, Donald C Obenhuber, PhD, Donald L Lech, Douglas A Campbell, Dr. Gopa Biswas, PhD, Emest F Bizjak, Emily J Orban, Eric L Dong, BS, Eric M Mueller, PharmD, Erika E Englund, PhD, Erika M Wilkerson, Felix Maldonado, Gayle S Lawson, George J Flynn, George Pyramides, Gifford Whitehurst, Jr, Helen B Ricalde, Jacqueline Mdiaz Albertini, Jaison J Eapen, James C Illuminati, James C Maclaughlin, James M Simpson, James R Birkenstamm, Javier E Santos, Jay T Wong, Jean Blackston Hill, Jean Blackstone Hill, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer J Stone, Jeremy W Rotton, Jingbo Xiao, Joanne Heim, Joanne M Hajoway, Joel D Hustedt, Joey C West, John D White, Jonathan W Chapman, Jorge L Guadalupe, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose R Hernandez, Joseph A Piechocki, Joseph J Vannelli, Joseph L Despins, PhD, Joseph R Strelnik, Julianne C Mccullough, Jullianne C Mccullough, Junho Pak, Justin A Boyd, Kalavati Suvarna, PhD, Karen A Briggs, Karen L Kosar, Karen M Montgomery (KMM), Karyn M Campbell, Katherine E Jacobitz, Kenneth Nieves, Kham Phommachanh, Kim Lthomas Cruse, Kristen D Evans, Kristina J Donohue, Kristina L Conroy, Kristina Mjoyce Pittman, Krystal O Ogunremi, L'oreal F Walker, Larry K Austin, Lata C Mathew, PhD, Latorie S Jones, Lauren Iacono Connors, PhD, Lawrence Harmon, Jr, Leigh Anne Myers, Liatte Kreuger, PharmD, Linda F Murphy, Lisa B Orr, Lisa Fecla, Lisa Feola, Lisa L Flores, Lisa M Bellows, LTJG Bradley E Benasutti, Luella Rossi, Luis A Dasta, Marcellinus D Dordunoo, Marcus A Ray, Marea K Harmon, Margaret M Annes, Margaret M Sands, Marion D Wimberly, Jr, Marshalette O Edwards, Mary E Storch, Matt D Suedkamp, Matthew R Dionne, Matthew R Noonan, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Melina Rodriguez Upton, Melissa J Garcia, Mercy Oyugi, Meyer J Slobotsky, Michael A Charles, Michael A Taylor, Michael F Skelly, PhD, Michael Gurbarg, Michael L Casner, Michael L Chasey, Michael P Sheehan, Michael R Goga, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michele M Falchek, Michele Perry Williams, Minh D Phan, Montgomery Montgomery, Karen M, Mra Davism, Mra Mcculloughj, Mra Munizn, Muna Algharibeh, Muralidhara B Gavini, PhD, Myra K Casey, Nailing Zhang, Nancy G Schmidt, Nancy M Espinal, Neali H Lucas, Nicholas A Violand, Nicholas L Paulin, Nicole E Knowlton, Nikki S Ramirez, Omotunde O Osunsanmi, Paraluman S Leonin, Parul M Patel, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patsy J Domingo, Paul L Bellamy, Paul L Figarole, Jr, Paul Mouris, Paula A Trost, Peter R Lenahan, Qiao Y Bobo, Qin Xu, Rabin N Ghoshal, Rachael O Oyewole, Rafeeq A Habeeb, Ralph A Erickson, Randy L Self, Raymond T Oji, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Richard E Needham, Richard J Friedman, Richard L Friedman, Robert B Shibuya, MD, Robert D Tollefsen, Robert J Ham, Robert J Maffei, Robert M Barbosa, Rochelle L Cross, Roger F Zabinski, Rose M Ashley, Rozelle G Smith, Ruark Lanham, Russell J Glapion, Sam Pepe, Samina S Khan, Sandra A Boyd, Scott T Ballard, Sharon K Thoma, PharmD, Shelley L Waring, Shirley J Berryman, Simone E Pitts, Sixto M Mercado Rios, Stephanie A Slater, MS, Stephanie Mangigian, MS/OSH, RN, Stephen J Koniers, Steven C Madzo, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susanna E Ford, Analyst, Suyang Qin, Tamara J Umscheid, Tamil Arasu, PhD, Tammy L Chavis, Ted L Anderson, Temar Q Williams, Terri L Dodds, Thomas E Friel, Thomas J Arista, Thomas W Nojek, Thuy T Nguyen, LCDR, Tina M Pawlowski, Torrance J Slayton, Truong Xuan Nguyen (Andy), Vilmary Negron Rodriguez, Viviana Matta, Vlada Matusovsky, Walden H Lee, Wayne E Seifert, William D Tingley, William V Millar, Xiaoping Guan, Yangmin Ning, Yumi J Hiramine, Zhihao Qiu (Peter), PhD

Luella J Rossi's Documents

Publish Date Document Type Title
January, 2004 FDA 483 BASF Aktiengesellshaft - Form 483, 2004-01-16
August, 2000 FDA 483 Response Veranova, L.P. - Form 483R, 2000-09-01
May, 2005 FDA 483 Eli Lilly and Company - Form 483, 2005-05-19
January, 2004 FDA 483 Noveal - Form 483, 2004-01-22
October, 2007 FDA 483 Merck Sharp & Dohme - Form 483, 2007-10-05
July, 2002 FDA 483 Eurofins Lancaster Laboratories, Inc - Form 483, 2002-07-25
January, 2004 EIR Noveal - EIR, 2004-03-05
July, 2003 FDA 483 Uquifa Italia S.p.A. - Form 483, 2003-07-02
January, 2004 EIR BASF SE - EIR, 2004-03-05
May, 2005 FDA 483 Response Eli Lilly and Company - Form 483R, 2005-05-19
January, 2004 FDA 483 Response Noveal - Form 483R, 2004-01-29
March, 2005 FDA 483 Cambrex Profarmaco Milano Srl - Form 483, 2005-03-03
July, 2003 EIR Uquifa Italia SpA - EIR, 2003-07-02
October, 2008 FDA 483 PEKANA Naturheilmittel GmbH - Form 483, 2008-10-02
August, 2000 EIR Veranova, L.P. - EIR, 2000-08-09
March, 2005 EIR Cambrex Profarmaco Milano Srl - EIR, 2005-03-03
August, 2000 FDA 483 Veranova, L.P. - Form 483, 2000-08-09
June, 2010 FDA 483 Confarma AG - Form 483, 2010-06-24
March, 2005 FDA 483 Response Cambrex Profarmaco Milano Srl - Form 483R, 2005-03-29
January, 2006 EIR Buchler GmbH - EIR, 2006-01-18
January, 2006 FDA 483 K+S KALI GmbH - Form 483, 2006-01-27
January, 2004 FDA 483 Response BASF SE - Form 483R, 2004-02-06
October, 2004 FDA 483 Biovail Technologies Ltd. - Form 483, 2004-10-29
July, 2003 FDA 483 Response Uquifa Italia SpA - Form 483R, 2003-07-31
May, 2005 EIR Eli Lilly and Company - EIR, 2005-05-19
July, 2002 EIR Eurofins Lancaster Laboratories, Inc - EIR, 2002-07-25

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more